Artivion (AORT) EBIT (QoQ) (2010 - 2026)
Artivion (AORT) EBIT (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Artivion | 1.37 Bn | 1.29 Bn | 80.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -244.53% |
| Mar 31, 2026 | -45.81% |
| Dec 31, 2025 | -14.81% |
| Sep 30, 2025 | 49.52% |
| Jun 30, 2025 | 290.86% |
| Mar 31, 2025 | -19.63% |
| Dec 31, 2024 | -39.16% |
| Sep 30, 2024 | -32.58% |
| Jun 30, 2024 | -74.29% |
| Mar 31, 2024 | 697.95% |
| Dec 31, 2023 | 354.98% |
| Sep 30, 2023 | -116.21% |
| Jun 30, 2023 | 298.78% |
| Mar 31, 2023 | -193.49% |
| Dec 31, 2022 | 200.58% |
| Sep 30, 2022 | -190.42% |
| Jun 30, 2022 | 177.57% |
| Mar 31, 2022 | 117.52% |
| Dec 31, 2021 | -163.59% |
| Sep 30, 2021 | 1,010.13% |